Organon & Co. (OGN)
13.79
+0.05
(+0.36%)
USD |
NYSE |
Oct 07, 16:00
13.78
-0.01
(-0.07%)
After-Hours: 20:00
Organon Market Cap : 3.621B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 3.621B |
| October 06, 2026 | 3.608B |
| October 05, 2026 | 3.598B |
| October 02, 2026 | 3.603B |
| October 01, 2026 | 3.600B |
| September 30, 2026 | 3.598B |
| September 29, 2026 | 3.608B |
| September 28, 2026 | 3.606B |
| September 25, 2026 | 3.606B |
| September 24, 2026 | 3.603B |
| September 23, 2026 | 3.606B |
| September 22, 2026 | 3.598B |
| September 21, 2026 | 3.592B |
| September 18, 2026 | 3.592B |
| September 17, 2026 | 3.595B |
| September 16, 2026 | 3.590B |
| September 15, 2026 | 3.587B |
| September 14, 2026 | 3.585B |
| September 11, 2026 | 3.582B |
| September 10, 2026 | 3.579B |
| September 09, 2026 | 3.590B |
| September 08, 2026 | 3.611B |
| September 04, 2026 | 3.619B |
| September 03, 2026 | 3.616B |
| September 02, 2026 | 3.616B |
| Date | Value |
|---|---|
| September 01, 2026 | 3.613B |
| August 31, 2026 | 3.613B |
| August 28, 2026 | 3.613B |
| August 27, 2026 | 3.613B |
| August 26, 2026 | 3.616B |
| August 25, 2026 | 3.611B |
| August 24, 2026 | 3.611B |
| August 21, 2026 | 3.611B |
| August 20, 2026 | 3.608B |
| August 19, 2026 | 3.606B |
| August 18, 2026 | 3.592B |
| August 17, 2026 | 3.598B |
| August 14, 2026 | 3.603B |
| August 13, 2026 | 3.603B |
| August 12, 2026 | 3.587B |
| August 11, 2026 | 3.585B |
| August 10, 2026 | 3.577B |
| August 07, 2026 | 3.571B |
| August 06, 2026 | 3.558B |
| August 05, 2026 | 3.564B |
| August 04, 2026 | 3.561B |
| August 03, 2026 | 3.561B |
| July 31, 2026 | 3.558B |
| July 30, 2026 | 3.558B |
| July 29, 2026 | 3.556B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 352.50B |
| Pfizer Inc. | 159.57B |
| Bristol Myers Squibb Co. | 121.97B |
| Harmony Biosciences Holdings, Inc. | 2.286B |
| ANI Pharmaceuticals, Inc. | 1.652B |
Market Cap Related Metrics
| PE Ratio | 17.67 |
| PS Ratio | 0.5932 |
| Price to Book Value | 3.600 |
| Price to Free Cash Flow | 6.513 |
| Price | 13.79 |
| Earnings Yield | 5.66% |
| Operating PE Ratio | 3.057 |
| Normalized PE Ratio | 9.112 |